A step-by-step technical guide to peptide reconstitution, subcutaneous injection technique, site rotation, storage, and dosage calculation — written to clinical research standards.
What "peptide injection" actually means: Research peptides typically come as a white powder (lyophilized, or freeze-dried) in a small glass vial. Before use in a laboratory setting, you mix them with sterile water to create a liquid solution. That solution is then administered via a very small insulin-style needle — the same kind used by diabetics to inject insulin. The needles are tiny (28–31 gauge) and the volumes are small (often less than half a teaspoon).
SubQ vs. IM — the simple version: "Subcutaneous" means just under the skin, into the fat layer. "Intramuscular" means into the muscle. For almost all research peptides, SubQ is the standard approach — it's less invasive, easier to do consistently, and produces a slower, more sustained absorption curve. Think of SubQ like a slow drip vs. IM like a faster flush.
Why reconstitution matters: The powder form is stable for months. Once you add water, the clock starts — most reconstituted peptides are only stable for 4–8 weeks in the refrigerator. This is why research protocols are designed around specific vial sizes and concentrations — you want to use the vial within its stable window. The calculator on this site handles all the math for you.
Bottom line: The process is more straightforward than it sounds. Mix powder with water, draw a precise volume into a small syringe, inject just under the skin. The step-by-step guide below walks through every part of this in detail.
The two primary routes of administration for research peptides are subcutaneous (SubQ) and intramuscular (IM). The choice of route affects absorption kinetics, onset of action, and the volume of solution that can be comfortably administered.
| Item | Specification | Notes |
|---|---|---|
| Peptide vial | Lyophilized, research-grade | Store at -20°C until use |
| Bacteriostatic water | 0.9% benzyl alcohol in sterile water | Do not use plain sterile water — no preservative |
| Insulin syringes | 28–31G, 0.5 inch, 1 mL | U-100 markings standard; use fresh syringe per injection |
| Alcohol swabs | 70% isopropyl alcohol | Wipe vial stopper and injection site; allow to dry |
| Sharps container | Puncture-resistant, labeled | Dispose of needles immediately after use |
| Refrigerator | 2–8°C (36–46°F) | For reconstituted peptide storage |
Standard subcutaneous injection protocol for research peptides.
Assemble all required materials before beginning: lyophilized peptide vial, bacteriostatic water (BAC water), insulin syringes (28–31G, 0.5 inch), alcohol swabs, and a sharps disposal container.
Before reconstituting, determine the concentration you want and the volume needed per dose. Use the CompoundReview Peptide Calculator for precise calculations.
Add bacteriostatic water to the lyophilized peptide vial using proper technique to preserve peptide integrity.
Using a fresh insulin syringe, draw the calculated dose volume from the reconstituted vial.
Select and prepare the subcutaneous injection site. Rotate sites to prevent tissue changes.
Administer the subcutaneous injection at a 45–90° angle and safely dispose of the needle.
The concentration of your reconstituted peptide solution determines the volume you draw per dose. The table below shows standard concentrations for common vial sizes.
| Vial Size | BAC Water Added | Concentration | 250 mcg dose = | 500 mcg dose = |
|---|---|---|---|---|
| 2 mg (2,000 mcg) | 1 mL | 2,000 mcg/mL | 0.125 mL (12.5 units) | 0.25 mL (25 units) |
| 5 mg (5,000 mcg) | 1 mL | 5,000 mcg/mL | 0.05 mL (5 units) | 0.10 mL (10 units) |
| 5 mg (5,000 mcg) | 2 mL | 2,500 mcg/mL | 0.10 mL (10 units) | 0.20 mL (20 units) |
| 10 mg (10,000 mcg) | 2 mL | 5,000 mcg/mL | 0.05 mL (5 units) | 0.10 mL (10 units) |
Consistent injection into the same site can cause lipodystrophy — localized changes in adipose tissue including lipoatrophy (fat loss) or lipohypertrophy (fat accumulation). Site rotation distributes injection trauma across a larger tissue area and maintains consistent absorption kinetics.
Largest surface area. Inject 2–3 inches from navel. Avoid the 1-inch zone directly around the navel. Divide into quadrants and rotate systematically.
Middle third of outer thigh. Avoid inner thigh and areas near the knee. Can be used when abdomen sites are fatigued.
Posterior aspect of upper arm, middle third. More difficult for self-administration. Typically requires assistance.
All compounds available with ≥99% purity, third-party COA verification, and cGMP-compliant manufacturing. Ships with bacteriostatic water.
View All Peptides at Purgo LabsUse code Health for 15% off · For research purposes only
Medical Disclaimer: All content on this site is for educational and research purposes only. Research peptides are not FDA-approved for human use. Always consult a qualified healthcare professional before considering any peptide or supplement protocol. Nothing on this site constitutes medical advice, diagnosis, or treatment.